Relay Therapeutics Inc. Common Stock vs State Street PDR S&P Retail ETF — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.08 (market cap $3.82B), while State Street PDR S&P Retail ETF trades at $83.74 (market cap $389.66M). The key difference: Relay Therapeutics Inc. Common Stock is far larger — about 9.8× State Street PDR S&P Retail ETF's market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and State Street PDR S&P Retail ETF for 44 Days on average.
| RLAY | XRT | |
|---|---|---|
Market Cap | $3.82B | $389.66M |
Volume | 4,332,079 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $20.75 | $92.35 |
52-Week Low | $6.03 | $77.28 |
Typical Hold Time | 0 Days | 44 Days |
Enterprise Value | $2.93B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XRT (SPDR S&P Retail ETF) trades at $83.45, up 0.65% with a bullish technical signal despite bearish moving averages. The ETF faces mixed sentiment as retail sales show volatility, with August's 1.2% rebound contrasting July's 0.6% decline. Key resistance sits at $85, while RSI-6 at 84.45 indicates potential overbought conditions. Recent news highlights holiday sales projections exceeding $1 trillion but concerns over consumer spending shifts toward value-oriented purchases.
Outlook remains cautious amid macroeconomic pressures; higher interest rates and inflation weigh on consumer sentiment, with analysts expecting continued underperformance versus broader markets. The ETF's equal-weight approach provides diversification, but selective consumer spending patterns and oil price volatility pose near-term risks. Investment appeal hinges on holiday season performance and Federal Reserve policy direction.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →